Posted 3/7/2024, 5:38:29 PM
Novo Nordisk Soars to 12th Most Valuable Company on Potential Blockbuster Obesity Drug
- Novo Nordisk stock reached all-time high, surpassing Tesla's market cap to become 12th most valuable company
- Early trial data shows Novo Nordisk's weight loss pill Amycretin helped users lose 13% body weight in 12 weeks
- Amycretin more effective than existing injections Ozempic and Wegovy for weight loss
- Novo Nordisk expanding beyond diabetes and obesity into cardiovascular medicine
- Booming sales of weight loss drugs could make Novo Nordisk one of first pharma companies valued at $1 trillion